Evgen Pharma (GB:TCF) has released an update.
Theracryf PLC has reported a noteworthy change in share ownership, with First Equity Limited and Armstrong Investments Limited, under the control of William Black, reaching a voting rights threshold of 6.01% on August 7, 2024. This change in voting power, resulting from an acquisition of shares, was officially notified to the company the following day. The event signifies a potential strategic shift in shareholder influence within the UK-based issuer.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
